Wealthcare Advisory Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$912K Sell
2,250
-188
-8% -$76.2K 0.02% 502
2025
Q1
$1.21M Sell
2,438
-2,668
-52% -$1.33M 0.03% 404
2024
Q4
$2.66M Sell
5,106
-85
-2% -$44.2K 0.07% 218
2024
Q3
$3.21M Sell
5,191
-53
-1% -$32.8K 0.09% 192
2024
Q2
$2.9M Sell
5,244
-90
-2% -$49.8K 0.09% 181
2024
Q1
$3.1M Buy
5,334
+4,172
+359% +$2.43M 0.1% 168
2023
Q4
$617K Sell
1,162
-72
-6% -$38.2K 0.02% 442
2023
Q3
$624K Sell
1,234
-73
-6% -$36.9K 0.03% 378
2023
Q2
$682K Sell
1,307
-9
-0.7% -$4.7K 0.03% 376
2023
Q1
$759K Buy
1,316
+59
+5% +$34K 0.03% 354
2022
Q4
$692K Buy
1,257
+179
+17% +$98.6K 0.03% 344
2022
Q3
$547K Buy
1,078
+295
+38% +$150K 0.03% 342
2022
Q2
$426K Buy
783
+101
+15% +$55K 0.03% 357
2022
Q1
$403K Buy
682
+26
+4% +$15.4K 0.02% 350
2021
Q4
$438K Buy
656
+38
+6% +$25.4K 0.03% 340
2021
Q3
$353K Buy
618
+67
+12% +$38.3K 0.02% 375
2021
Q2
$278K Buy
551
+22
+4% +$11.1K 0.02% 441
2021
Q1
$242K Buy
+529
New +$242K 0.02% 445
2020
Q2
Sell
-209
Closed -$59K 1251
2020
Q1
$59K Sell
209
-44
-17% -$12.4K 0.01% 478
2019
Q4
$82K Sell
253
-14
-5% -$4.54K 0.01% 441
2019
Q3
$78K Sell
267
-14
-5% -$4.09K 0.01% 444
2019
Q2
$83K Buy
281
+14
+5% +$4.14K 0.01% 418
2019
Q1
$73K Buy
267
+79
+42% +$21.6K 0.01% 400
2018
Q4
$42K Hold
188
0.01% 468
2018
Q3
$46K Hold
188
0.01% 488
2018
Q2
$39K Buy
188
+47
+33% +$9.75K 0.01% 517
2018
Q1
$29K Sell
141
-97
-41% -$20K 0.01% 518
2017
Q4
$45K Buy
238
+132
+125% +$25K 0.01% 391
2017
Q3
$20K Buy
+106
New +$20K 0.01% 431